Direct biomarkers of microbial translocation correlate with immune activation in adult Zambians with environmental enteropathy and hepatosplenic schistosomiasis

American Journal of Tropical Medicine and Hygiene

Volumn 97, Issue 5, 2017, Pages 1603-1610

  Kaonga, Patrick ^a   Kaimoyo, Evans ^d   Besa, Ellen ^a   Zyambo, Kanekwa ^a   Sinkala, Edford ^b   Kelly, Paul ^a,c  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RNA 16S; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; BACTERIAL DNA; CYTOKINE; LIPOPROTEIN; LIPOTEICHOIC ACID; TEICHOIC ACID;

ADULT; ANIMAL CELL; ARTICLE; BACTERIAL TRANSLOCATION; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; ENTEROPATHY; FEMALE; GENE DOSAGE; HUMAN; IMMUNE RESPONSE; LIMULUS LYSATE TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS; ZAMBIAN; ANIMAL; BLOOD; HOST PARASITE INTERACTION; IMMUNOLOGY; MIDDLE AGED; MOUSE; RAW 264.7 CELL LINE; YOUNG ADULT; ZAMBIA;

ADULT; ANIMALS; BACTERIAL TRANSLOCATION; BIOMARKERS; CROSS-SECTIONAL STUDIES; CYTOKINES; DNA, BACTERIAL; FEMALE; GENE DOSAGE; HOST-PARASITE INTERACTIONS; HUMANS; INTESTINAL DISEASES; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MALE; MICE; MIDDLE AGED; RAW 264.7 CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SCHISTOSOMIASIS; TEICHOIC ACIDS; YOUNG ADULT; ZAMBIA;

EID: 85034041025     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.17-0365     Document Type: Article

References (57)

1. Korpe PS, Petri WA, 2012. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med 18: 328–336.
2. Kelly P, Besa E, Zyambo K, Louis-Auguste J, Lees J, Banda T, Soko R, Banda R, Amadi B, Watson A, 2016. Endomicroscopic and transcriptomic analysis of impaired barrier function and malabsorption in environmental enteropathy. PLoS Negl Trop Dis 10: e0004600.
3. Campbell DI, Murch SH, Elia M, Sullivan PB, Sanyang MS, Jobarteh B, Lunn PG, 2003. Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr Res 54: 306–311.
4. Yu J, Ordiz MI, Stauber J, Shaikh N, Trehan I, Barnell E, Head RD, Maleta K, Tarr PI, Manary MJ, 2016. Environmental enteric dysfunction includes a broad spectrum of inflammatory responses and epithelial repair processes. Cell Mol Gastroenterol Hepatol 2: 158–174.e1.
5. Vlachogiannakos J, Viazis N, Vasianopoulou P, Vafiadis I, Karamanolis DG, Ladas SD, 2013. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol 28: 450–455.
6. Mutengo MM, Mwansa JCL, Mduluza T, Sianongo S, Chipeta J, 2014. High Schistosoma mansoni disease burden in a rural district of western Zambia. Am J Trop Med Hyg 91: 965–972.
7. Sinkala E, Kapulu MC, Besa E, Zyambo K, Chisoso NJ, Foster GR, Kelly P, 2016. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis. Liver Int 36: 145–150.
8. Kelly P, Besa E, Lees J, Banda T, Zyambo K, Muchimba M, Watson A, Louis-Auguste J, 2015. PTH-231 pathways of epithelial leakage and zinc malabsorption in environmental enteropathy imaged by confocal endomicroscopy. Gut 64: A511–A512.
9. Uddin MI, Islam S, Nishat NS, Hossain M, Rafique TA, Rashu R, Hoq MR, Zhang Y, Saha A, Harris JB, 2016. Biomarkers of environmental enteropathy are positively associated with immune responses to an oral cholera vaccine in Bangladeshi children. PLoS Negl Trop Dis 10: e0005039.
10. Kramski M, Gaeguta AJ, Lichtfuss GF, Rajasuriar R, Crowe SM, French MA, Lewin SR, Center RJ, Purcell DFJ, 2011. Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation. J Clin Microbiol 49: 3691–3693.
11. Abad-Fernandez M, Vallejo A, Hernandez-Novoa B, Diaz L, Gutierrez C, Madrid N, Munoz MA, Moreno S, 2013. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals. J Acquir Immune Defic Syndr 64: 149–153.
12. Ulevitch RJ, Tobias PS, 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13: 437–457.
13. Kelly P, et al., 2004. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 70: 412–419.
14. Louis-Auguste J,Greenwald S,Simuyandi M, Soko R, Banda R, Kelly P, 2014. High dose multiple micronutrient supplementation improves villous morphology in environmental enteropathy without HIV enteropathy: results from a double-blind randomised placebo controlled trial in Zambian adults. BMC Gastroenterol 14: 1–10.
15. Wilmotte A, Van der Auwera G, De Wachter R, 1993. Structure of the 16 S ribosomal RNA of the thermophilic cyanobacterium Chlorogloeopsis HTF (‘Mastigocladus laminosus HTF’) strain PCC7518, and phylogenetic analysis. FEBS Lett 317: 96–100.
16. Dittmar R, Potier E, van Zandvoort M, Ito K, 2012. Assessment of cell viability in three-dimensional scaffolds using cellular auto-fluorescence. Tissue Eng Part C Methods 18: 198–204.
17. Turner JR, 2009. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799–809.
18. Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD, 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut 56: 61–72.
19. Marchetti G, et al., 2011. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 25: 1385–1394.
20. Yoon S-B, Lee Y-J, Park SK, Kim H-C, Bae H, Kim HM, Ko S-G, Choi HY, Oh MS, Park W, 2009. Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J Ethnopharmacol 125: 286–290.
21. Dungey M, Hull KL, Smith AC, Burton JO, Bishop NC, 2013. Inflammatory factors and exercise in chronic kidney disease. Int J Endocrinol 2013: 12.
22. Pastor Rojo O, Lopez San Roman A, Albeniz Arbizu E, de la Hera Martinez A, Ripoll Sevillano E, Albillos Martinez A, 2007. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 13: 269–277.
23. Brenchley JM, et al., 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365–1371.
24. Jiang W, et al., 2009. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 199: 1177–1785.
25. Prendergast A, Kelly P, 2012. Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg 86: 756–763.
26. D’Ettorre G, et al., 2011. HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. Curr HIV Res 9: 148–153.
27. Ferri E, Novati S, Casiraghi M, Sambri V, Genco F, Gulminetti R, Bandi C, 2010. Plasma levels of bacterial DNA in HIV infection: the limits of quantitative polymerase chain reaction. J Infect Dis 202: 176–177.
28. Moriyama K, Ando C, Tashiro K, Kuhara S, Okamura S, Nakano S, Takagi Y, Miki T, Nakashima Y, Hirakawa H, 2008. Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood. Microbiol Immunol 52: 375–382.
29. Pasternak BA, et al., 2010. Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn’s disease and murine colitis. Inflamm Bowel Dis 16: 856–869.
30. Hao XP, et al., 2015. Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection. Nat Commun 6: 8020.
31. Brown EM, et al., 2015. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun 6: 7806.
32. Holland-Fischer P, Gronbaek H, Sandahl TD, Moestrup SK, Riggio O, Ridola L, Aagaard NK, Moller HJ, Vilstrup H, 2011. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS. Gut 60: 1389–1393.
33. Ellwardt E, Zipp F, 2014. Molecular mechanisms linking neuro-inflammation and neurodegenerationin MS. ExpNeurol 262:8–17.
34. Kitchens RL, Thompson PA, 2005. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225–229.
35. Sandler NG, et al., 2011 Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780–790.
36. Shrivastava AK, Singh HV, Raizada A, Singh SK, 2015. C-reactive protein, inflammation and coronary heart disease. Egypt Heart J 67: 89–97.
37. Elbaz T, Esmat G, 2013. Hepatic and intestinal schistosomiasis Review. J Adv Res 4: 445–452.
38. Kosek M, et al., 2014. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Nephrol Dial Transplant 59: S239–S247.
39. Park W, 2014. Immunomodulatory effects of Lycii radicis cortex water extract on lipopolysaccharide-activated RAW 264.7 mouse macrophages. J Pharm Nutr Sci 4: 207–212.
40. Zhou HF, et al., 2011. Biflavonoids from Caper (Capparis spinosa L.) fruits and their effects in inhibiting NF-kappa B activation. J Agric Food Chem 59: 3060–3065.
41. Lewis RE, Liao G, Young K, Douglas C, Kontoyiannis DP, 2014. Macrophage reporter cell assay for screening immunopharma-cological activity of cell wall-active antifungals. Antimicrob Agents Chemother 58: 1738–1743.
42. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, Collins JE, 2005. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85: 1139–1162.
43. Chiba H, Kojima T, Osanai M, Sawada N, 2006. The significance of interferon-γ–triggered internalization of tight-junction proteins in inflammatory bowel disease. Sci STKE 2006: pe1.
44. Walsh SV, Hopkins AM, Nusrat A, 2000. Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 41: 303–313.
45. Szliszka E, Mertas A, Czuba ZP, Król W, 2013. Inhibition of inflammatory response by Artepillin C in activated RAW264. 7 macrophages. Evid Based Complement Alternat Med 2013: 735176.
46. Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat AM, 1993. Analysis of enteropathy induced by tumour necrosis factor α. Cytokine 5: 24–30.
47. Kaser A, Ludwiczek O, Waldenberger P, Jaschke W, Vogel W, Tilg H, 2002. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 22: 380–387.
48. Tilg H, Moschen AR, Kaser A, 2009. Obesity and the microbiota. Gastroenterology 136: 1476–1483.
49. Xiao Y-T, Yan W-H, Cao Y, Yan J-K, Cai W, 2016. Neutralization of IL-6 and TNF-α ameliorates intestinal permeability in DSS-induced colitis. Cytokine 83: 189–192.
50. Suzuki T, Yoshinaga N, Tanabe S, 2011. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286: 31263–31271.
51. Funderburg NT, et al., 2013. Circulating CD4+ and CD8+ T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 140: 87–97.
52. Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, Bancroft GJ, Lertmemongkolchai G, 2017. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei. Sci Rep 7: 42791.
53. Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D, 2014. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm 2014: 561459.
54. Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Gangl A, Rutgeerts P, 2000. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease. Gastroenterology 119: 1461–1472.
55. Pan D, Kenway-Lynch CS, Lala W, Veazey RS, Lackner AA, Das A, Pahar B, 2014. Lack of interleukin-10-mediated anti-inflammatory signals and upregulated interferon gamma production are linked to increased intestinal epithelial cell apoptosis in pathogenic Simian immunodeficiency virus infection. J Virol 88: 13015–13028.
56. Pradervand S, Maurya MR, Subramaniam S, 2006. Identification of signaling components required for the prediction of cytokine release in RAW 264.7 macrophages. Genome Biol 7: 1.
57. Mocellin S, Marincola F, Rossi CR, Nitti D, Lise M, 2004. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev 15: 61–76.